Gattefossé India has set up for the first in India a Maharashtra FDA approved pharmaceutical application testing lab in Mumbai for quality testing pharma ingredients and product development. The lab will also assist pharma companies in India to use ingredients for better product quality and efficacy.

Officially inaugurated in the presence of Jacques Moyrand, Gattefossé group chairman, Ajit Singh, chairman, ACG Worldwide Associated Capsule Pvt Ltd and Yves Perrin, the consul general of France, the laboratory will serve formulation development needs for customer projects to ensure product quality and also cater to in-house global technical requirements.
 
Sunil Bambarkar, managing director of Gattefossé India, explains, “We strongly believe that Gattefossé India with its well-equipped, FDA approved lab can widen its horizon and offer technical support not only to India but also to the region. This centre delivers services pertaining to the use of Gattefossé excipients in pharmaceutical dosage formulations and personal care formulations.”

Gattefossé India is affiliated to French company Gattefossé which develops, manufactures and sells specialty ingredients for the personal care and pharmaceutical industries. Gattefossé India- the Gattefossé affiliate is responsible for sales, marketing and technical service support throughout the Indian subcontinent.

Olivier Midler, CEO of Gattefossé group describes its vision for the future, “Our growth strategy for the company is based on two main pillars; innovation, by pursuing our significant investments in R&D and product applications, and geographical expansion by developing our business and expertise in new territories. All these efforts are to ensure our customers a responsive and adapted service specific to their markets.”

The laboratory comprises two distinct areas; the first one is dedicated to develop oral solid dosage forms. It is a well equipped facility including the following machines like tablet compression press (ELIZA PRESS 200 motorised with IPPC & AWC facility), jacketed rapid mixer granulator (Saizonizer mixer granulator cap - 10 L), octagonal blender of 5, 2 and 1 litre(s) capacity- GMP model, vibro sifter (VSFT – 300 single deck) - GMP model, co-mill - GMP model, hot air oven for drying the formulated granules, various IPQC equipments namely hardness tester, disintegration time tester, tablet friability, tester, electromagnetic sieve shaker and tap densitometer. The second demonstration area is dedicated to conduct in-house micro-emulsion, suppository and topical workshops and laboratory scale formulations.

Personal care laboratory offers formulation development for personal care projects. Various workshops demonstrating Gattefossé expertise in developing cosmetic formulations and illustrating the sensorial benefits offered by emulsifiers and texture agents are conducted. An extensive range of ready-to-use prototypes using Gattefossé ingredients is proposed, taking into consideration the regional psyche and needs of Indian customers.

Analytical laboratory is a common facility for both pharmaceutical and personal care products where the developed formulations are evaluated using analytical instruments.

Says Dr Chhanda Kapadia, technical vice-president, Gattefossé India, “Our mission is to generate innovative applications of our excipients by engaging in cutting-edge research which would act as a valuable resource to the industry. It is also about identifying areas of specialisation upon which the technical centre can concentrate, based on an informed perception of Indian, regional and global needs. Finally, our objective is also to undertake collaborative projects which offer opportunities for long-term interactions with the academia and the industry.”